| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017013486 | 2017-01-27 |
| Publication Number | Publication Date |
|---|---|
| SG10202108219QAtrue SG10202108219QA (en) | 2021-08-30 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10202108219QASG10202108219QA (en) | 2017-01-27 | 2018-01-26 | Prophylactic and/or therapeutic agent of infectious disease or inflammatory disease |
| SG11201906968YASG11201906968YA (en) | 2017-01-27 | 2018-01-26 | Prophylactic and/or therapeutic agent of infectious disease or inflammatory disease |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201906968YASG11201906968YA (en) | 2017-01-27 | 2018-01-26 | Prophylactic and/or therapeutic agent of infectious disease or inflammatory disease |
| Country | Link |
|---|---|
| US (2) | US20190367600A1 (en) |
| EP (2) | EP4317431A3 (en) |
| JP (1) | JP7126658B2 (en) |
| KR (1) | KR102581165B1 (en) |
| CN (1) | CN110267680B (en) |
| AU (1) | AU2018213716B2 (en) |
| CA (1) | CA3051826A1 (en) |
| SG (2) | SG10202108219QA (en) |
| WO (1) | WO2018139608A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3155346A1 (en)* | 2019-10-30 | 2021-05-06 | National University Corporation Okayama University | Prophylactic and/or therapeutic agent for inflammatory pulmonary disease |
| CN119317838A (en) | 2022-06-30 | 2025-01-14 | 株式会社Ａ－Ｃｌｉｐ研究所 | Method for examining the state of vasculitis or the risk of severe COVID-19, examination kit, companion diagnostic reagent, and examination marker |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US164290A (en) | 1875-06-08 | Improvement in bedsteads | ||
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| AU669124B2 (en) | 1991-09-18 | 1996-05-30 | Kyowa Hakko Kirin Co., Ltd. | Process for producing humanized chimera antibody |
| JP2000014383A (en) | 1998-07-03 | 2000-01-18 | Igaku Seibutsugaku Kenkyusho:Kk | Humanized antibodies |
| FR2801407B1 (en) | 1999-11-22 | 2002-04-12 | Roger Felix Sejalon | CONTINUOUSLY TRACABLE INVIOLABLE LABEL BRACELET |
| US20030022330A1 (en) | 2001-04-19 | 2003-01-30 | Myriad Genetics, Incorporated | APOA2-interacting proteins and use thereof |
| JP2004081199A (en) | 2002-06-25 | 2004-03-18 | Sekisui Chem Co Ltd | Method for producing recombinant antibody |
| US9028822B2 (en)* | 2002-06-28 | 2015-05-12 | Domantis Limited | Antagonists against TNFR1 and methods of use therefor |
| JP3965147B2 (en) | 2003-11-04 | 2007-08-29 | ヤンマー株式会社 | Claw shaft attachment / detachment structure of rotary tiller |
| EP1697746B1 (en)* | 2003-12-05 | 2012-02-22 | The Cleveland Clinic Foundation | Risk markers for cardiovascular disease |
| GB0701626D0 (en)* | 2007-01-22 | 2007-03-07 | Cambridge Entpr Ltd | Methods and biomarkers for diagnosing and monitoring psychotic disorders |
| EP2126109A2 (en)* | 2007-03-19 | 2009-12-02 | Sirtris Pharmaceuticals, Inc. | Biomarkers of sirtuin activity and methods of use thereof |
| WO2009032702A2 (en) | 2007-08-28 | 2009-03-12 | Uab Research Foundation | Synthetic apolipoprotein e mimicking polypeptides and methods of use |
| WO2009044723A1 (en)* | 2007-10-04 | 2009-04-09 | Biomarker Science Co., Ltd. | Method for prediction of effect of interferon therapy and kit for prediction |
| GB0720976D0 (en)* | 2007-10-26 | 2007-12-05 | Medical Res Council | Treatment of inflammatory disease |
| US8225183B2 (en) | 2008-09-30 | 2012-07-17 | Lsi Corporation | Methods and apparatus for selective data retention decoding in a hard disk drive |
| US9435813B2 (en)* | 2010-05-11 | 2016-09-06 | The General Hospital Corporation | Biomarkers of hemorrhagic shock |
| WO2012039161A1 (en) | 2010-09-22 | 2012-03-29 | 国立大学法人 千葉大学 | Novel testing method and testing reagent for angiitis |
| US10196457B2 (en)* | 2011-12-19 | 2019-02-05 | National University Corporation Chiba University | Artificial immunoglobulin fragment composition |
| US10208131B2 (en)* | 2011-12-19 | 2019-02-19 | National University Corporation Chiba University | Artificially produced polyclonal immunoglobulin preparation |
| CA3189276A1 (en)* | 2013-10-01 | 2015-04-09 | Toray Industries, Inc. | Method for detecting pancreatic tumor, antibodies, and kit for the detection of pancreatic tumor |
| JP5685672B1 (en) | 2014-07-10 | 2015-03-18 | 株式会社山岡製作所 | Resin molding method |
| US11231423B2 (en)* | 2015-01-26 | 2022-01-25 | Toray Industries, Inc. | Method and kit for the detection of biliary tract cancer |
| JP6670129B2 (en)* | 2015-02-27 | 2020-03-18 | 国立大学法人千葉大学 | Artificial immunoglobulin fragment composition |
| WO2016140210A1 (en)* | 2015-03-02 | 2016-09-09 | 東レ株式会社 | Pancreatic dysfunction detection method and detection kit |
| US9895848B2 (en) | 2015-04-22 | 2018-02-20 | The Boeing Company | Systems and tooling for manufacturing composite parts and related methods |
| JP6453199B2 (en) | 2015-10-16 | 2019-01-16 | 光洋機械工業株式会社 | Centerless grinding machine |
| Publication number | Publication date |
|---|---|
| JP7126658B2 (en) | 2022-08-29 |
| WO2018139608A1 (en) | 2018-08-02 |
| KR20190108152A (en) | 2019-09-23 |
| CN110267680B (en) | 2023-12-19 |
| EP3581204A1 (en) | 2019-12-18 |
| AU2018213716B2 (en) | 2025-01-30 |
| US20190367600A1 (en) | 2019-12-05 |
| CA3051826A1 (en) | 2018-08-02 |
| AU2018213716A1 (en) | 2019-08-15 |
| US12281158B2 (en) | 2025-04-22 |
| SG11201906968YA (en) | 2019-08-27 |
| US20220213180A1 (en) | 2022-07-07 |
| EP3581204A4 (en) | 2020-12-16 |
| CN110267680A (en) | 2019-09-20 |
| EP4317431A2 (en) | 2024-02-07 |
| KR102581165B1 (en) | 2023-09-21 |
| JPWO2018139608A1 (en) | 2020-01-09 |
| EP4317431A3 (en) | 2024-05-22 |
| Publication | Publication Date | Title |
|---|---|---|
| IL274276A (en) | Casz compositions and methods of use | |
| GB2582100B (en) | CAS12C Compositions and methods of use | |
| IL273959A (en) | Methods and compositions for the treatment of rare diseases | |
| PT3723752T (en) | New solid forms of cannabidiol and uses thereof | |
| ZA201906169B (en) | Synthekine compositions and methods of use | |
| IL244317B (en) | Cortistatin analogues for the treatment of inflammatory and/or immune diseases | |
| IL269158A (en) | Preparations and methods for the treatment of inflammatory diseases | |
| SG11201912185XA (en) | Three dimensional tissue compositions and methods of use | |
| IL285928A (en) | Fulvestrant formulations and methods of their use | |
| IL247368A0 (en) | Diagnostic and therapeutic uses of exosomes | |
| ZA201800037B (en) | Diagnosis and treatment of infectious disease | |
| IL272937A (en) | Compositions and methods for the treatment of fibrotic diseases | |
| IL266132B (en) | Pharmaceutical formulations and methods of making the same | |
| GB2615479B (en) | Therapeutic and prophylactic use of microoganisms | |
| IL274433A (en) | Fulvestrant formulations and methods of their use | |
| SG11202002316PA (en) | Prophylactic and/or therapeutic agent for diseases involving ido expression | |
| SG10202108219QA (en) | Prophylactic and/or therapeutic agent of infectious disease or inflammatory disease | |
| IL252779A0 (en) | Prevention and treatment of inflammatory diseases | |
| ZA201906964B (en) | Prevention and/or treatment of inflammatory skin disease | |
| SG11201704430SA (en) | Preventive and/or therapeutic agent of immune disease | |
| IL272604A (en) | Methods and compositions for treatment of inflammatory bowel disease | |
| GB201522329D0 (en) | Use of adjuvants for the prevention and/or treatment of autoimmune diseases | |
| PT3664800T (en) | Therapeutic formulations and uses thereof | |
| EP3272349A4 (en) | Therapeutic and/or prophylactic agent for lewy body diseases | |
| SMT202400086T1 (en) | Preparation for the treatment and/or prophylaxis of inflammatory infectious diseases |